Mahuang: ancientherb, modern medicine, regulatory dilemma.HerbalGram 34: 22-26, 43, 56, 57.Chen, K. K. 1974. Half a century of ephedrine.American J. Chinese Med. 2: 359-365.Israelsen, L. 1997. Ephedra ... an insider'sperspective. Herbs for Health 2(3): 50, 51.Mahdihassan, S. 1988. Ephedra, the oldest medicinalplant with a history of uninterrupted use. Ancient Sci.Life 7: 105-109.McCaleb, R. S. 1995. Perspective on Ephedra,ephedrine, and caffeine products. HerbalGram 34: 27,42.Turk, M. P. 1997. Ephedrine's deadly edge. U. S. News& World Report 123(1): 79, 80.White, L. M. et al. 1997. Pharmacokinetics andcardiovascular effects of ma-huang (Ephedra sinica) innormotensive adults. J. Clin. Pharm. 37: 116-122.ERGOTBarger, G. 1931. Ergot and ergotism. Guerney &Jackson. London, England. 279 pp.Bennett, J. W. 1999. Pride and prejudice: the story ofergot. Perspective in Biol. and Med. 42(3): 333-355.Berde, B. & H. O. Schild (editors). 1978. Ergotalkaloids and related compounds. Springer. Berlin,Germany. 905 pp.Bove, F. J. 1970. The story of ergot. S. Karger. NewYork, NY. 297 pp.Hofmann, A. 1958. The chemistry of the ergotalkaloids. Planta Med. 6: 381-394.Hofmann, A. 1964. Die Mutterkornalkaloide. FernandEnke. Stuttgart, Germany. 218 pp.Hofmann, A. 1972. Ergot -- a rich source ofpharmacologically active substances. In, Swain, T.(editor). Plants in the development of modernmedicine. Harvard Univ. Press. Cambridge, MA. Pp.235-260.Kren, V. & L. Cvak (editors). 1998. Ergot, the genusClaviceps. Harwood Academic. 537 pp.Rehacek, Z. & P. Sajdl. 1993. Ergot alkaloids:chemistry, biological effects, biotechnology. ElsevierScience Publ. New York, NY. 383 pp,Spanos, N. P. 1983. Ergotism and the Salem witchpanic: a critical analysis and an alternativeconceptualization. J. Hist. Behav. Sci. 19(4): 358-369.Van Dongen, P. W. J. & A. N. J. A. De Groot. 1995.History of ergot alkaloids from ergotism toergometrine. European J. Obs. Gyn. Reprod. Biol. 60:109-116.Youngken, H. W., Jr. 1947. Ergot -- a blessing and ascourge. Econ. Bot. 1(4): 372-380.FEVERFEWAwang, D. V. C. 1989. Feverfew. Canadian Pharm. J.122(5): 266-270.Baldwin, C.A. 1987. What pharmacists should knowabout feverfew. Pharm. 3. 239: 237, 238.Foster, S. 1991. Feverfew: Tanacetum parthenium.American Bot. Council. Austin, TX. 8 pp.Foster, S. 1998. Researchers find feverfew does helpmigraines. Herbs for Health 3(1): 17.-343-Groenewegen, W. A. & S. Heptinstall. 1986. Amountsof feverfew in commercial preparations of the herb.Lancet 1: 44, 45.Hobbs, C. 1989. Feverfew: a review. HerbalGram 20:26-25; 47.Johnson, E. S. et al. 1985. Efficacy of feverfew asprophylactic treatment for migraine. British Med. J.291: 569-573.Knight, D. W. 1995. Feverfew: chemistry andbiological activity. Natural Prod. Rep. 12: 271-276.Murphy, J. et al. 1988. Randomized double-blindplacebo-controlled trial of feverfew in migraineprevention. Lancet July 23: 189-192.Vickers, H. R. 1985. Feverfew and migraine. BritishMed. J. 291: 827.Waller, P. C. & L. Ramsay. 1985. Efficacy of feverfewas prophylactic treatment of migraine. British Med. J.291: 1128.FOXGLOVEAntman, E. M. & T. W. Smith. 1985. Digitalis toxicity.Ann. Rev. Med. 36: 357-367.Aronson, J. K. 1985. An account of the foxglove andits medical uses, 1785-1985. Oxford Univ. Press.London, England.Cagin, N. A. et al. 1977. Digitalis: new knowledgeabout an old drug. Cardiovascular Medicine. Pp. 183-192.Estes, J. W. & P. D. White. 1965. William Witheringand the purple foxglove. Sci. American 212(6): 110-117.Krikler, D. M. 1985. Withering and the foxglove: themaking of a myth. British Heart J. 54: 256.Krikler, D. M. 1985. The foxglove: the old womanfrom Shropshire and William Withering. J. AmericanColl. Cardiol. 5: Suppl: A3.Lee, T. C. 1981. Van Gogh's vision, digitalisintoxication? J. American Med. Assoc. XX: 727.Marullaz, P. D. 1991. Digitalis: is there a future forthis classical ethnopharmacological remedy? J.Ethnopharm. 32(1-3): 111-115.GARLICAdetumbi, M. A. & B. H. S. Leu. 1983. Allium sativum(garlic) -- a natural antibiotic. Med. Hypotheses 12:227-237.Anonymous. 1998. Garlic goodness and how to get it.Herbs for Health 3 (5): 63-65.Bergner, P. 1996. The healing power of garlic -- theenlightened person's guide to nature's most versatilemedicinal plant. Prima Publ. Rocklin, CA. 290 pp.Bleumink, E. et al. 1972. Allergic contact dermatitis togarlic. British J. Dermatol. 87: 6-9.Foster, S. 1997. Curbing cholesterol with garlic. Herbsfor Health 1(4): 28, 29.Jain, A. K. et al. 1993. Can garlic reduce levels ofserum lipids? A controlled clinical study. American J.Med. 94: 632-635.Jain, R. C. et al. 1973. Hypoglycaemic action of onionand garlic. Lancet 2: 1491.Kendler, B. S. 1987. Garlic (Allium sativum) and onion(Allium cepa): a review of their relationship tocardiovascular disease. Prev. Med. 16: 670-685.Kleijnen, J. et al. 1989. Garlic, onions andcardiovascular risk factors. A review of the evidencefrom human experiments with emphasis oncommercially available preparations. British J. Clin.Pharm. 28: 535-544.Koch, H. P. & L. D. Lawson (editors). 1996. Garlic: thescience and therapeutic application of Allium sativumL. and related species. Williams & Wilkins. Baltimore,MD. 340 pp.Morien, K. 1998. Modest cholesterol effect with garlic.HerbalGram 44: 17.Reuter, H. D. 1995. Allium sativum and Alliumursinum. Part 2. Pharmacology and medicinalapplication. Phytomed. 2(1): 73-91.Seligmann, J. & G. Cowley. 1995. Sex, lies and garlic.Newsweek CXXVI(19): 65-68.Silagy, C. A. & H. A. Neil. 1994. A meta-analysis ofthe effect of garlic on blood pressure. J. Hypertension12: 463-468.Silagy, C. A. & H. A. Neil. 1994. Garlic as a lipidlowering agent: a meta-analysis. J. Royal Coll. Phys. (London) 28: 39-45.Tolton, S. et al. 1982. The medical uses of garlic --fact and fiction. American Pharm. 22: 448-451.Webb, G. 1996. Conference report: garlic symposiumof the 6th annual phytotherapy congress. Berlin.HerbalGram 36: 62, 63.Wolkomir, R. 1995. Without garlic, life would be justplain tasteless. Smithsonian 26(9): 70-76, 78, 79.GINGERFoster, S. 1999. Ginger: a multicultural remedy.Herbs for Health 4(4): 60-63.Fulder, S. & M. Tenne. 1996. Ginger as an anti-nausearemedy in pregnancy: the issue of safety. HerbalGram38: 47-50.Mowrey, D. B. & D. E. Clayson. 1982. Motion sickness,ginger, and psychophysics. Lancet 1: 655-657.Mustafa, T. et al. 1993. Pharmacology of ginger,Zingiber officinale. J. Drug Devel. 6: 25-39.Schulick, P. 1996. Ginger: common spice and wonderdrug. Third edition. Herbal Free Press. Brattleboro, VT.166 pp.Stewart, J. J. et al. 1991. Effects of ginger on motionsickness susceptibility and gastric function.Pharmacology 42: 111-120.GINKGOBeek, T. A. 2000. Ginkgo biloba. Harwood Acad.Amsterdam, The Netherlands. 548 pp.-344-Braquet, P. 1988-89. Ginkgolides: chemistry, biology,pharmacology and clinical perspectives. Two vols. J. R.Prous. Barcelona, Spain.Crowley, G. & K. Springen. 1997. Brain boosters.Newsweek 130(18): 58, 59.DeFeudis, F. V. 1991. Ginkgo biloba extract (EGB761): pharmacological activities and clinicalapplications. Elsevier. Paris, France.De Feudis, F. 1998. Ginkgo biloba extract (EGB 761):from chemistry to the clinic. 401 pp. Elden, H. R. 1990. Ginsenosides -- new uses for an oldroot. Drug Cosmetic Indust. Apr: 36-40.Gorman, C. 1997. More than a funny name. Time150(18): 94.Halpern, G. 1998. Ginkgo: a practical guide. AveryPubl. Garden City Park, NY. 172 pp.Hori, T. et al. (editors). 1997. Ginkgo biloba: a globalteasure: from biology to medicine. Springer. Tokyo.427 pp.Itil, T. M. et al. 1996. Central nervous system effectsof Ginkgo biloba, a plant extract. American J.Therapeutics 3: 63-73.Jones, K. 1998. Computer helps measure ginkgo'sbrain benefits. Herbs for Health 3(1): 65.Kleijnen, J. & P. Knipschild. 1992. Drug profiles:Ginkgo biloba. Lancet 340: 1136-1139.Kleijnen, J. & P. Knipchild. 1992. Ginkgo biloba forcerebral insufficiency. British J. Clin. Pharm. 34: 352-358.Le Bars, P. L. et al. 1997. A placebo-controlled,double-blind, randomized trial of an extract of Ginkgobiloba for dementia. J. American Med. Assoc. 278(16):1327-1332.Oken, B. S. et al. 1998. The efficacy of Ginkgo bilobaon cognitive function in Alzheimer disease. Arch.Neurol. 134(11): 1409-1415.Purkh, K. & S. Khalsa. 1997. Survival skills: ginkgoand conditions associated with aging. Herbs for Health2(2): 37-39.Smith, P. F. et al. 1996. The neuroprotectiveproperties of the Ginkgo biloba leaf: a review of thepossible relationship to platelet-activating factor(PAF). J. Ethnopharm. 50(3): 131-139.GINSENGAwang, D. V. C. 2003. What in the name of Panax arethose other "ginsengs?" HerbalGram 57: 30-35.Baldwin, C. 1971. Green gold from the forest.American Forests 77(4): 40-43.Baldwin, C. A. et al. 1986. What pharmacists shouldknow about ginseng. Pharm. J. 237: 583-586.Baranov, A. 1966. Recent advances in our knowledgeof the morphology, cultivation and uses of ginseng(Panax ginseng C. A. Meyer). Econ. Bot. 20(4): 403-406.Baranov, A. L. 1982. Medicinal uses of ginseng andrelated plants in the Soviet Union: recent trends inSoviet literature. J. Ethnopharm. 6: 339-353.Barna, P. 1985. Food or drug? The case of ginseng.Lancet 2: 548.Bilger, B. 2002. Wild sang: rangers, poachers, androots that cost a thousand dollars a pound. NewYorker LXXVIII(19): 38-45.Carlson, A. W. 1986. Ginseng: America's botanicaldrug connection to the Orient. Econ. Bot. 40(2): 233-249.Chong, S. K. & V. G. Oberholzer. 1988. Ginseng: isthere a use in clinical medicine? Postgrad. Med. J. 64:841-846.Dharmananda, S. 2002. The nature of ginseng.HerbalGram 54: 34-51.Duke, J. A. 1989. Ginseng: a concise handbook.Reference Publ. Algonac, MI. 273 pp.Foster, S. 1997. Roots of steel: increase stamina withSiberian ginseng. Herbs for Health 2(3): 31-35.Fulder, S. 1977. Ginseng: useless root or subtlemedicine. New Scientist 73: 138-.Goldstein, B. 1975. Ginseng: its history, dispersion,and folk tradition. American J. Chinese Med. 3(3):223-234.Hemmerly, T. E. 1977. A ginseng farm in LawrenceCounty, Tennessee. Econ. Bot. 31(2): 160-162., C. 1997. Ginseng: facts and folklore. Herbs forHealth 2(1): 34-38.Hou, J. P. 1979. The myth and truth about ginseng. A.S. Barnes & Co. South Brunswick, NJ. 245 pp.Hu, S. Y. 1976. The genus Panax (ginseng) in Chinesemedicine. Econ. Bot. 30: 11-28.Hu, S. Y. 1977. A contribution to our knowledge ofginseng. American J. Chinese Med. 5: 1-23.Li, T. S. C. & G. Mazza. 1996. Ginsenosides in rootsand leaves of American ginseng. J. Agric. Food Chem.44: 717-720.Liu, C.-X. & P.-G. Xiao. 1992. Recent advances onginseng research in China. J. Ethnopharm. 36(1): 27-38.McCaleb, R. 1988. Ginseng conference report. Herbal-Gram 16: 8-12.Persons, W. S. 1994. American ginseng: green gold.Revised edition. Bright Mountain Books. Asheville, NC.203 pp.Phillipson, C. D. 1984. Ginseng -- quality, safety, andefficacy. Pharm. J. 232: 161-165.Proctor, J. T. A. & W. G. Bailey. 1987. Ginseng:industry, botany, and culture. Hort. Rev. 9: 188-236.Roberts, C. R. 1980. American ginseng/Panaxquinquefolia. Acta Hort. 96: 85-90.Rodale, R. 1973. Ginseng: a plant worth knowing.Organic Gard. Farm. 20: 34-39.-345-Shibata, S. et al.